HealthPelacarsen fails to reduce heart disease risk in 8,350 participant trial.An experimental drug, pelacarsen, designed to lower lipoprotein(a) levels and reduce heart attack and stroke risks, failed to show any reduction in cardiovascular complications during a critical trial...NPR Health · 8 days ago · 2 min read